Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
---|---|---|---|---|---|
PMID:16249068 | IVR | 4500 mg/L | 4500 mg/L | Decreased spleen weights | Immunological endocrine-mediated perturbations |
IVR | 4500 mg/L | 4500 mg/L | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 4500 mg/L | 4500 mg/L | Increased liver weights | Hepatic endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Increased liver weights | Hepatic endocrine-mediated perturbations | |
IVR | 750 mg/kg | 750 mg/kg | Anophthalmia | Developmental endocrine-mediated perturbations | |
IVR | 750 mg/kg | 750 mg/kg | Changes in ovarian morphology | Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg | 750 mg/kg | Affects skeletal development | Developmental endocrine-mediated perturbations | |
IVR | 750 mg/kg | 750 mg/kg | Affects testis development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 750 mg/kg | 750 mg/kg | Increased liver weights | Hepatic endocrine-mediated perturbations | |
IVR | 750 mg/kg | 750 mg/kg | Affects survival of live fetus | Reproductive endocrine-mediated perturbations | |
IVR | 300 mg/kg | 300 mg/kg | Increased liver weights | Hepatic endocrine-mediated perturbations | |
IVR | 8000 mg/L | 8000 mg/L | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 8000 mg/L | 8000 mg/L | Increased liver weights | Hepatic endocrine-mediated perturbations | |
IVR | 8000 mg/L | 8000 mg/L | Decreased spleen weights | Immunological endocrine-mediated perturbations | |
IVR | 1000 mg/L | - | No significant effects observed | - | |
PMID:21633115 | IVR | 300 mg/kg/day | 300 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations |
IVR | 600 mg/kg/day | 600 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 900 mg/kg/day | 900 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | - | No significant effects observed | - |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.